Financial Ratios

ANG LIFESCIENCES INDIA LTD.

NSE : NABSE : 540694ISIN CODE : INE236W01016Industry : Pharmaceuticals & DrugsHouse : Private
BSE57.400.15 (+0.26 %)
PREV CLOSE ( ) 57.25
OPEN PRICE ( ) 56.02
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 4076
TODAY'S LOW / HIGH ( )56.02 58.69
52 WK LOW / HIGH ( ) 44.4989.89
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)-0.5138.3113.9911.7610.90
   CEPS(Rs)6.0134.607.325.655.23
   DPS(Rs)0.001.000.000.000.00
   Book NAV/Share(Rs)65.5080.5379.7966.6755.50
   Tax Rate(%)132.0025.1626.4827.4930.33
Margin Ratios
   Core EBITDA Margin(%)5.6318.809.9410.009.72
   EBIT Margin(%)6.2717.608.979.368.99
   Pre Tax Margin(%)1.0015.226.396.636.66
   PAT Margin (%)-0.3211.394.704.814.64
   Cash Profit Margin (%)3.7912.866.155.775.57
Performance Ratios
   ROA(%)-0.2519.356.156.977.58
   ROE(%)-0.7863.6219.1019.2521.75
   ROCE(%)9.1853.7819.9022.3923.66
   Asset Turnover(x)0.791.701.311.451.63
   Sales/Fixed Asset(x)1.964.964.323.823.80
   Working Capital/Sales(x)9.4712.617.705.826.93
Efficiency Ratios
   Fixed Capital/Sales(x)0.510.200.230.260.26
   Receivable days156.1482.58124.03126.36110.82
   Inventory Days58.6825.3534.6223.8021.41
   Payable days159.2988.47124.6997.6591.68
Valuation Parameters
   PER(x)0.004.902.451.031.76
   PCE(x)12.645.424.692.143.67
   Price/Book(x)1.162.911.080.450.86
   Yield(%)0.000.430.000.000.00
   EV/Net Sales(x)0.710.850.560.260.35
   EV/Core EBITDA(x)6.794.485.402.513.52
   EV/EBIT(x)11.244.856.272.773.88
   EV/CE(x)0.581.110.610.350.52
   M Cap / Sales0.480.700.290.120.20
Growth Ratio
   Net Sales Growth(%)-40.63126.0021.644.2260.04
   Core EBITDA Growth(%)-67.66313.5122.768.6247.27
   EBIT Growth(%)-78.84343.3116.638.5556.29
   PAT Growth(%)-101.67447.7918.937.9151.69
   EPS Growth(%)-101.32173.9018.937.9151.69
Financial Stability Ratios
   Total Debt/Equity(x)0.620.731.030.600.76
   Current Ratio(x)1.151.181.221.431.41
   Quick Ratio(x)0.890.991.011.231.26
   Interest Cover(x)1.197.383.473.433.87
   Total Debt/Mcap(x)0.530.250.951.330.88

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.